BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bednarska O, Walter SA, Casado-Bedmar M, Ström M, Salvo-Romero E, Vicario M, Mayer EA, Keita ÅV. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Gastroenterology 2017;153:948-960.e3. [PMID: 28711627 DOI: 10.1053/j.gastro.2017.06.051] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Struffert M, Maier C, Neid M, Schäfer HL, Tannapfel A, Schmidt-Choudhury A. Duodenal mast cells and eosinophils in children with celiac disease: occurrence and distribution pattern. Scand J Gastroenterol 2021;:1-9. [PMID: 34618623 DOI: 10.1080/00365521.2021.1985601] [Reference Citation Analysis]
2 Liu YW, Hui HY, Tan ZJ. Gastrointestinal peptide hormones associated with brain-intestinal axis. Shijie Huaren Xiaohua Zazhi 2019; 27(16): 1007-1012 [DOI: 10.11569/wcjd.v27.i16.1007] [Reference Citation Analysis]
3 Casado-Bedmar M, Keita ÅV. Potential neuro-immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13:1756284820910630. [PMID: 32313554 DOI: 10.1177/1756284820910630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol 2020;32:706-12. [PMID: 32317585 DOI: 10.1097/MEG.0000000000001737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Meira de-Faria F, Casado-Bedmar M, Mårten Lindqvist C, Jones MP, Walter SA, Keita ÅV. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14130. [PMID: 33797165 DOI: 10.1111/nmo.14130] [Reference Citation Analysis]
6 Cheng L, Luo QQ, Chen SL. The role of intestinal mast cell infiltration in irritable bowel syndrome. J Dig Dis 2021;22:143-51. [PMID: 33511763 DOI: 10.1111/1751-2980.12971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, De Winter BY, Grover M. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol 2021;14:1756284821993586. [PMID: 33717210 DOI: 10.1177/1756284821993586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therap Adv Gastroenterol 2020;13:1756284819897531. [PMID: 32047534 DOI: 10.1177/1756284819897531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Reference Citation Analysis]
10 Andrews CN, Sidani S, Marshall JK. Clinical Management of the Microbiome in Irritable Bowel Syndrome. J Can Assoc Gastroenterol 2021;4:36-43. [PMID: 33644675 DOI: 10.1093/jcag/gwz037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Yuan W, Hou S, Jia H, Qiu Z, Liu T, Chen X, Li H, Sun Y, Liang L, Sui X, Zhao X, Zhao Z. Ketotifen fumarate attenuates feline gingivitis related with gingival microenvironment modulation. Int Immunopharmacol 2018;65:159-73. [PMID: 30316074 DOI: 10.1016/j.intimp.2018.10.006] [Reference Citation Analysis]
12 Beeckmans D, Farré R, Riethorst D, Keita ÅV, Augustijns P, Söderholm JD, Vanuytsel T, Vanheel H, Tack J. Relationship between bile salts, bacterial translocation, and duodenal mucosal integrity in functional dyspepsia. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yakabi S, Wang L, Karasawa H, Yuan PQ, Koike K, Yakabi K, Taché Y. VIP is involved in peripheral CRF-induced stimulation of propulsive colonic motor function and diarrhea in male rats. Am J Physiol Gastrointest Liver Physiol 2018;314:G610-22. [PMID: 29420068 DOI: 10.1152/ajpgi.00308.2017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology 2019;157:391-402.e2. [PMID: 31022401 DOI: 10.1053/j.gastro.2019.04.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
15 Galiazzo G, Giancola F, Stanzani A, Fracassi F, Bernardini C, Forni M, Pietra M, Chiocchetti R. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract. Histochem Cell Biol 2018;150:187-205. [DOI: 10.1007/s00418-018-1684-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
16 Rupp SK, Stengel A. Bi-Directionality of the Microbiota-Gut-Brain Axis in Patients With Functional Dyspepsia: Relevance of Psychotherapy and Probiotics. Front Neurosci 2022;16:844564. [DOI: 10.3389/fnins.2022.844564] [Reference Citation Analysis]
17 Jacobson A, Yang D, Vella M, Chiu IM. The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol 2021;14:555-65. [PMID: 33542493 DOI: 10.1038/s41385-020-00368-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
18 Xu H, Shi X, Li X, Zou J, Zhou C, Liu W, Shao H, Chen H, Shi L. Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review. J Neuroinflammation 2020;17:356. [PMID: 33239034 DOI: 10.1186/s12974-020-02029-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Casado-Bedmar M, de-Faria FM, Biskou O, Lindqvist CM, Ranasinghe PD, Bednarska O, Peterson C, Walter SA, Carlson M, Keita ÅV. Elevated F-EDN correlates with mucosal eosinophil degranulation in patients with IBS-A possible association with microbiota? J Leukoc Biol 2021. [PMID: 34151454 DOI: 10.1002/JLB.4A0521-228R] [Reference Citation Analysis]
20 Simon RA, Ranasinghe PD, Barazanji N, Jungeström MB, Xu J, Bednarska O, Serrander L, Engström M, Bazylinski DA, Keita ÅV, Walter S. Magnetotactic bacteria from the human gut microbiome associated with orientation and navigation regions of the brain. J Ocean Limnol 2021;39:2044-52. [DOI: 10.1007/s00343-021-0495-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019; 25(10): 1185-1196 [PMID: 30886502 DOI: 10.3748/wjg.v25.i10.1185] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Schwerdtfeger LA, Tobet SA. Vasoactive intestinal peptide regulates ileal goblet cell production in mice. Physiol Rep 2020;8:e14363. [PMID: 32026594 DOI: 10.14814/phy2.14363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
23 Friesen H, Singh M, Singh V, Schurman JV, Friesen CA. A Survey of Methodologies for Assessing Mast Cell Density and Activation in Patients with Functional Abdominal Pain Disorders. GastrointestDisord 2021;3:142-55. [DOI: 10.3390/gidisord3040016] [Reference Citation Analysis]
24 Witt ST, Bednarska O, Keita ÅV, Icenhour A, Jones MP, Elsenbruch S, Söderholm JD, Engström M, Mayer EA, Walter S. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome. Neuroimage Clin 2019;21:101602. [PMID: 30472166 DOI: 10.1016/j.nicl.2018.11.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
25 De Bruyn M, Ceuleers H, Hanning N, Berg M, De Man JG, Hulpiau P, Hermans C, Stenman UH, Koistinen H, Lambeir AM, De Winter BY, De Meester I. Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis. Int J Mol Sci 2021;22:10711. [PMID: 34639054 DOI: 10.3390/ijms221910711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Katinios G, Casado-Bedmar M, Walter SA, Vicario M, González-Castro AM, Bednarska O, Söderholm JD, Hjortswang H, Keita ÅV. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health. Inflamm Bowel Dis 2020;26:974-84. [PMID: 31944236 DOI: 10.1093/ibd/izz328] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
27 Li YJ, Li J, Dai C. The Role of Intestinal Microbiota and Mast Cell in a Rat Model of Visceral Hypersensitivity. J Neurogastroenterol Motil 2020;26:529-38. [PMID: 32989188 DOI: 10.5056/jnm20004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Norlin A, Walter S, Icenhour A, Keita ÅV, Elsenbruch S, Bednarska O, Jones MP, Simon R, Engström M. Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity. Brain, Behavior, and Immunity 2021;92:211-20. [DOI: 10.1016/j.bbi.2020.11.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Casado-Bedmar M, Heil SDS, Myrelid P, Söderholm JD, Keita ÅV. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis. Neurogastroenterol Motil 2019;31:e13503. [PMID: 30407703 DOI: 10.1111/nmo.13503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
30 Keita ÅV, Söderholm JD. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Curr Opin Pharmacol 2018;43:66-71. [PMID: 30216901 DOI: 10.1016/j.coph.2018.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
31 Takashima S, Tanaka F, Kawaguchi Y, Usui Y, Fujimoto K, Nadatani Y, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Tanigawa T, Watanabe T, Imoto S, Uematsu S, Fujiwara Y. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice. Neurogastroenterol Motil 2020;32:e13841. [PMID: 32319196 DOI: 10.1111/nmo.13841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Shen J, Zhang B, Chen J, Cheng J, Wang J, Zheng X, Lan Y, Zhang X. SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway. JIR 2022;Volume 15:1745-56. [DOI: 10.2147/jir.s331303] [Reference Citation Analysis]
33 Roberti MP, Rauber C, Kroemer G, Zitvogel L. Impact of the ileal microbiota on colon cancer. Semin Cancer Biol 2021:S1044-579X(21)00250-9. [PMID: 34624451 DOI: 10.1016/j.semcancer.2021.09.016] [Reference Citation Analysis]
34 Wauters L, Ceulemans M, Schol J, Farré R, Tack J, Vanuytsel T. The Role of Leaky Gut in Functional Dyspepsia. Front Neurosci 2022;16:851012. [DOI: 10.3389/fnins.2022.851012] [Reference Citation Analysis]
35 Colomier E, Algera J, Melchior C. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front Pharmacol 2020;11:629026. [PMID: 33679391 DOI: 10.3389/fphar.2020.629026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ganda Mall JP, Löfvendahl L, Lindqvist CM, Brummer RJ, Keita ÅV, Schoultz I. Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms. Sci Rep 2018;8:13404. [PMID: 30194322 DOI: 10.1038/s41598-018-31492-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
37 Meira de-Faria F, Bednarska O, Ström M, Söderholm JD, Walter SA, Keita ÅV. Colonic paracellular permeability and circulating zonulin-related proteins. Scand J Gastroenterol 2021;56:424-31. [PMID: 33535002 DOI: 10.1080/00365521.2021.1879247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 St John AL, Rathore APS, Ginhoux F. New perspectives on the origins and heterogeneity of mast cells. Nat Rev Immunol 2022. [PMID: 35610312 DOI: 10.1038/s41577-022-00731-2] [Reference Citation Analysis]
39 Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets 2020;24:511-23. [PMID: 32249629 DOI: 10.1080/14728222.2020.1752181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
40 Palma AM, Hanes MR, Marshall JS. Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence. Front Immunol 2021;12:718499. [PMID: 34566974 DOI: 10.3389/fimmu.2021.718499] [Reference Citation Analysis]
41 Chao G, Wang Z, Zhang S. Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome. J Inflamm Res 2021;14:1427-36. [PMID: 33883919 DOI: 10.2147/JIR.S300513] [Reference Citation Analysis]
42 Stanzani A, Galiazzo G, Giancola F, Tagliavia C, De Silva M, Pietra M, Fracassi F, Chiocchetti R. Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract. Histochem Cell Biol 2020;153:339-56. [PMID: 32095931 DOI: 10.1007/s00418-020-01854-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
43 Algera JP, Störsrud S, Lindström A, Simrén M, Törnblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clin Nutr 2021;40:5365-72. [PMID: 34560607 DOI: 10.1016/j.clnu.2021.09.002] [Reference Citation Analysis]
44 Farré R, Vicario M. Maintaining Intestinal Mucosal Integrity by Plugging Leaks with Homoectoine. Dig Dis Sci 2019;64:292-3. [PMID: 30467675 DOI: 10.1007/s10620-018-5383-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Ceulemans M, Wauters L, Accarie A, Vanuytsel T. Stress-induced changes in healthy mice do not reflect functional dyspepsia pathophysiology. Neurogastroenterol Motil 2020;32:e13940. [PMID: 32671945 DOI: 10.1111/nmo.13940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 López-gómez L, Bagüés A, Uranga JA, Abalo R. Preclinical models of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome. Elsevier; 2020. pp. 233-76. [DOI: 10.1016/b978-0-12-821324-7.00012-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Shin A, Preidis GA, Shulman R, Kashyap PC. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol 2019;17:256-74. [PMID: 30153517 DOI: 10.1016/j.cgh.2018.08.054] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
48 Suzuki F, Loucas BD, Ito I, Asai A, Suzuki S, Kobayashi M. Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation. J Immunol 2018;201:77-86. [PMID: 29743312 DOI: 10.4049/jimmunol.1701515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
49 Tao E, Zhu Z, Hu C, Long G, Chen B, Guo R, Fang M, Jiang M. Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome. Front Cell Neurosci 2022;16:837166. [DOI: 10.3389/fncel.2022.837166] [Reference Citation Analysis]
50 Pérez de Arce E, Quera R, Beltrán CJ, Madrid AM, Nos P. Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis? Gastroenterol Hepatol 2021:S0210-5705(21)00143-6. [PMID: 34023477 DOI: 10.1016/j.gastrohep.2021.02.022] [Reference Citation Analysis]
51 Sundin J, Nordlander S, Eutamene H, Alquier‐bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Schoultz I, Keita ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells 2020;9:E1909. [PMID: 32824536 DOI: 10.3390/cells9081909] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
53 Ganda Mall JP, Östlund-Lagerström L, Lindqvist CM, Algilani S, Rasoal D, Repsilber D, Brummer RJ, Keita ÅV, Schoultz I. Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? BMC Geriatr 2018;18:75. [PMID: 29554871 DOI: 10.1186/s12877-018-0767-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
54 Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Res 2019;8:F1000 Faculty Rev-1629. [PMID: 31559013 DOI: 10.12688/f1000research.18039.1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
55 Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C, Santos J, Vicario M. Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis. Cells 2019;8:E135. [PMID: 30744042 DOI: 10.3390/cells8020135] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 17.3] [Reference Citation Analysis]
56 Alesci A, Pergolizzi S, Fumia A, Calabrò C, Lo Cascio P, Lauriano ER. Mast cells in goldfish ( Carassius auratus ) gut: Immunohistochemical characterization. Acta Zoologica. [DOI: 10.1111/azo.12417] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
57 Forsythe P. Mast Cells in Neuroimmune Interactions. Trends in Neurosciences 2019;42:43-55. [DOI: 10.1016/j.tins.2018.09.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
58 Matisz C, Gruber A. Neuroinflammatory remodeling of the anterior cingulate cortex as a key driver of mood disorders in gastrointestinal disease and disorders. Neuroscience & Biobehavioral Reviews 2022;133:104497. [DOI: 10.1016/j.neubiorev.2021.12.020] [Reference Citation Analysis]
59 Makowska K, Obremski K, Gonkowski S. The Impact of T-2 Toxin on Vasoactive Intestinal Polypeptide-Like Immunoreactive (VIP-LI) Nerve Structures in the Wall of the Porcine Stomach and Duodenum. Toxins (Basel) 2018;10:E138. [PMID: 29587461 DOI: 10.3390/toxins10040138] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
60 Mars RAT, Frith M, Kashyap PC. Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic? Gastroenterology 2021;160:538-55. [PMID: 33253687 DOI: 10.1053/j.gastro.2020.10.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
61 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]